Baytril 2.5% Oral

Target species Calves Exotic Animals (small mammals, reptiles and avian species) 4.2 Indications for use, specifying the target species The product is for use in calves in the treatment of infections of the alimentary and respiratory tracts of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis and salmonellosis), where clinical experience supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. The product may also be used in exotic animals (small mammals, reptiles and avian species) for the treatment of bacterial infections of the alimentary and respiratory tracts where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. 4.3 Contraindications The product should not be used for prophylaxis. 4.4 Special warnings for each target species Exotic Animals: Consult the Technical Services Department of Bayer prior to use. 4.5 Special precautions for use i) Special precautions for use in animals See 4.4. Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. ii) Special precautions to be taken by the person administering the medicinal product to animals Wear impervious gloves when handling the product. Wash any splashes from skin or eyes immediately with water. Wash hands and exposed skin after use. Do not eat, drink or smoke whilst using the product. iii) Other precautions None. 4.6 Adverse reactions (frequency and seriousness) During the period of rapid growth, enrofloxacin may affect articular cartilage. 4.7 Use during pregnancy, lactation or lay In the absence of data on its use in some exotic species, caution should be used when prescribing during these periods and a careful risk/benefit assessment made. 4.8 Interaction with other medicinal products and other forms of interaction None known.
Vat Rate: 20%